Display Settings:

Format

Send to:

Choose Destination
Milbank Q. 2004;82(4):661-87.

Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages.

Author information

  • 1University of California, Davis, CA, USA. rlkravitz@ucdavis.edu

Erratum in

  • Milbank Q. 2006;84(4):759-60.

Abstract

Evidence-based medicine is the application of scientific evidence to clinical practice. This article discusses the difficulties of applying global evidence ("average effects" measured as population means) to local problems (individual patients or groups who might depart from the population average). It argues that the benefit or harm of most treatments in clinical trials can be misleading and fail to reveal the potentially complex mixture of substantial benefits for some, little benefit for many, and harm for a few. Heterogeneity of treatment effects reflects patient diversity in risk of disease, responsiveness to treatment, vulnerability to adverse effects, and utility for different outcomes. Recognizing these factors, researchers can design studies that better characterize who will benefit from medical treatments, and clinicians and policymakers can make better use of the results.

PMID:
15595946
[PubMed - indexed for MEDLINE]
PMCID:
PMC2690188
Free PMC Article

Images from this publication.See all images (3)Free text

Figure 1
Figure 2
Figure 3
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Blackwell Publishing Icon for PubMed Central
    Loading ...
    Write to the Help Desk